Daily non-political popular news in brief.

Taking Cancer's Fingerprint: Rapid genetic profiling for personalized therapy

02-17-2007 · Science News Online

A new, faster way to identify cancer-causing mutations in the DNA of tumor cells may pave the way for the next generation of custom-tailored cancer therapies.

Keywords: taking, cancer, fingerprint, rapid, genetic, profiling, personalized, therapy

« Previous | Next »

Similar news on "Taking Cancer's Fingerprint: Rapid genetic profiling for personalized therapy":

Genes and biomarkers that allow doctors to choose the right therapy for the right patient
04-17-2007 · EurekAlert!
Genetic and epigenetic variations ensure that no two people are exactly alike, and the same holds true for any two cancers. Now, researchers have the tools and the knowledge to help predict how individuals will respond to cancer therapies, enabling them to create more effective therapies for individual cancers -- personalized medicine.
Similar news · Read more »
Gene variations point to why lung cancer drugs work better in Japanese vs. US patients
06-02-2007 · EurekAlert!
Recent clinical trials revealed that Japanese lung cancer patients survived longer and had a higher rate of side effects than US patients taking the same two drugs, paclitaxel and carboplatin. Now a new study by the Southwest Oncology Group uncovers genetic differences that may explain why. The results, embargoed for release 8:30 a.m. ET Saturday, June 2, are being highlighted at the American Society of Clinical Oncology annual meeting.
Similar news · Read more »
Personalized medicine can cut breast cancer risk
02-15-2008 · EurekAlert!
The time has come for breast cancer risk assessment, counseling and genetic testing to move from cancer specialists to the realm of primary care. A growing body of evidence has documented the benefits of preventive measures for high-risk women including those with mutations in the BRCA1 and BRCA2 genes. Referral for cancer-risk assessment and BRCA testing in the primary care setting is a necessary step towards personalized medicine for women at risk.
Similar news · Read more »
Custom-made cancer cell attacks
02-16-2007 · EurekAlert!
Imagine a cancer treatment tailored to the cells in a patient’s body, each person receiving a unique treatment program. This is what Natural Sciences and Engineering Research Council grantee Thomas Ruth and his colleagues hope to accomplish within the next decade. Using the TRIUMF particle accelerator based in Vancouver, British Columbia, they are taking vast amounts of radioactive material and separating the particular atoms they need for therapy
Similar news · Read more »
Jefferson pharmacologist says biomarker discovery bodes well for better cancer diagnostics
05-01-2007 · EurekAlert!
A pharmacologist at the Kimmel Cancer Center at Jefferson says that new findings suggesting a genetic marker can help distinguish between chronic pancreatitis and pancreatic cancer and gauge who will do well with cancer treatment have important implications for improved cancer diagnostics and tumor profiling. In an editorial he co-authored May 2 in JAMA, Scott Waldman, M.D., Ph.D., says that researchers at Ohio State University have identified "a new level of biological regulation."
Similar news · Read more »
Team demos safety of RNA therapy
09-26-2007 · EurekAlert!
Researchers from MIT, Alnylam Pharmaceuticals and other institutions have demonstrated the safety of a promising type of genetic therapy that could lead to treatments for a wide range of diseases such as cancer.
Similar news · Read more »
Personalized diets may offer relief to advanced cancer patients
03-09-2007 · EurekAlert!
Researchers at the University of Alberta studying the effects of chemotherapy and radiation therapy on the senses report that most advanced cancer patients experience unique and persistent taste and smell abnormalities, believed to be a key factor in malnutrition and poor quality of life. Their study suggests that every patient with chemosensory dysfunction has unique symptoms, and a diet tailored to his/her needs would likely improve quality of life.
Similar news · Read more »
Women with breast cancer do not get potentially life-saving information, survey reveals
05-24-2007 · EurekAlert!
New published data from a large pan-European survey indicate that the majority of postmenopausal women with early breast cancer taking post-surgical endocrine therapy are not involved in making key decisions about their treatment, nor are they given sufficient information to make informed treatment choices that could affect their long-term outcome.
Similar news · Read more »
Pre-treatment blood test could guide lung cancer therapy
06-05-2007 · EurekAlert!
A multi-center team, led by Vanderbilt-Ingram Cancer Center investigators, has developed a new pre-treatment blood test that predicts which non-small-cell lung cancer patients will live longer when they are treated with certain targeted cancer therapies (Iressa, Tarceva). The mass spectrometry-based test, described in the June 6 Journal of the National Cancer Institute, may allow physicians to select the most beneficial therapy for each lung cancer patient, a step forward in the era of personalized medicine.
Similar news · Read more »
Genetic variation impacts aspirin's effectiveness in preventing colon cancer, Dartmouth study finds
10-24-2006 · EurekAlert!
Dartmouth researchers are among a team of doctors that have learned more about how people may or may not benefit from taking aspirin in the effort to curb colon cancer.
Similar news · Read more »